Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: Effects of NMDA receptor blockade

Journal of Neurochemistry

Volumn 107, Issue 5, 2008, Pages 1347-1357

  Russo, R ^a   Cavaliere, F ^a   Berliocchi, L ^a   Nucci, C ^b   Gliozzi, M ^c   Mazzei, C ^a   Tassorelli, C ^d   Corasaniti, M T ^b,c   Rotiroti, D ^c   Bagetta, G ^a   Morrone, L A ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Akt; Excitoxicity; MK801; PI3K; Retinal ischemia

Indexed keywords

DIZOCILPINE; GLYCOGEN SYNTHASE KINASE 3BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MODEL; INTRAOCULAR PRESSURE; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; RETINA GANGLION CELL; RETINA INJURY; RETINA ISCHEMIA;

ANALYSIS OF VARIANCE; ANDROSTADIENES; ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; CELL DEATH; CHROMONES; DIZOCILPINE MALEATE; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; INTRAOCULAR PRESSURE; ISCHEMIA; MALE; MORPHOLINES; ONCOGENE PROTEIN V-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REPERFUSION INJURY; RETINAL DISEASES; SERINE; SIGNAL TRANSDUCTION; TIME FACTORS;

RATTUS;

EID: 55849144802     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05694.x     Document Type: Article

References (49)

1. Adachi K., Kashii S., Masai H., Ueda M., Morizane C., Kaneda K., Kume T., Akaike A. Honda Y. (1998) Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch. Clin. Exp. Ophthalmol. 236, 766 774.
2. Ahn Y. M., Seo M. S., Kim S. H., Kim Y., Yoon S. C., Juhnn Y. S. Kim Y. S. (2005) Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection. Int. J. Neuropsychopharmacol. 8, 607 613.
3. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P. Hemmings B. A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541 6551.
4. Beurel E. Jope R. S. (2006) The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 79, 173 189.
5. Brazil D. P. Hemmings B. A. (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26, 657 664.
6. Buchi E. R. (1992) Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp. Eye Res. 55, 605 613.
7. Buchi E. R., Suivaizdis I. Fu J. (1991) Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica 203, 138 147.
8. Cheung Z. H., Chan Y. M., Siu F. K., Yip H. K., Wu W., Leung M. C. So K. F. (2004) Regulation of caspase activation in axotomized retinal ganglion cells. Mol. Cell. Neurosci. 25, 383 393.
9. Chong Z. Z., Kang J. Q. Maiese K. (2002) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106, 2973 2979.
10. Corasaniti M. T., Maiuolo J., Maida S., Fratto V., Navarra M., Russo R., Amantea D., Morrone L. A. Bagetta G. (2007) Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro. Br. J. Pharmacol. 151, 518 529.
11. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M. Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785 789.
12. Datta S. R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y. Greenberg M. E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231 241.
13. Davies S. P., Reddy H., Caivano M. Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95 105.
14. Franke T. F., Hornik C. P., Segev L., Shostak G. A. Sugimoto C. (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22, 8983 8998.
15. Fukunaga K. Kawano T. (2003) Akt is a molecular target for signal transduction therapy in brain ischemic insult. J. Pharmacol. Sci. 92, 317 327.
16. Gupta N. Weinreb R. N. (1997) New definitions of glaucoma. Curr. Opin. Ophthalmol. 8, 38 41.
17. Huang Y., Cen L. P., Luo J. M., Wang N., Zhang M. Z., van Rooijen N., Pang C. P. Cui Q. (2008) Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension. Neuroscience 153, 214 225.
18. Ikeda K., Tatsuno T., Noguchi H. Nakayama C. (2004) Ciliary neurotrophic factor protects rat retina cells in vitro and in vivo via PI3 kinase. Curr. Eye Res. 29, 349 355.
19. Joo C. K., Choi J. S., Ko H. W., Park K. Y., Sohn S., Chun M. H., Oh Y. J. Gwag B. J. (1999) Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest. Ophthalmol. Vis. Sci. 40, 713 720.
20. Kanamori A., Nakamura M., Nakanishi Y., Nagai A., Mukuno H., Yamada Y. Negi A. (2004) Akt is activated via insulin/IGF-1 receptor in rat retina with episcleral vein cauterization. Brain Res. 1022, 195 204.
21. Kelly S., Zhao H., Hua Sun G., Cheng D., Qiao Y., Luo J., Martin K., Steinberg G. K., Harrison S. D. Yenari M. A. (2004) Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp. Neurol. 188, 378 386.
22. Kim H. S. Park C. K. (2005) Retinal ganglion cell death is delayed by activation of retinal intrinsic cell survival program. Brain Res. 1057, 17 28.
23. Klocker N., Kermer P., Weishaupt J. H., Labes M., Ankerhold R. Bahr M. (2000) Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3′-kinase/protein kinase B signaling. J. Neurosci. 20, 6962 6967.
24. Konishi H., Fujiyoshi T., Fukui Y., Matsuzaki H., Yamamoto T., Ono Y., Andjelkovic M., Hemmings B. A. Kikkawa U. (1999) Activation of protein kinase B induced by H(2)O(2) and heat shock through distinct mechanisms dependent and independent of phosphatidylinositol 3-kinase. J. Biochem. 126, 1136 1143.
25. Levkovitch-Verbin H., Harizman N., Dardik R., Nisgav Y., Vander S. Melamed S. (2007) Regulation of cell death and survival pathways in experimental glaucoma. Exp. Eye Res. 85, 250 258.
26. Levy D. I. Lipton S. A. (1990) Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology 40, 852 855.
27. Louzada-Junior P., Dias J. J., Santos W. F., Lachat J. J., Bradford H. F. Coutinho-Netto J. (1992) Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59, 358 363.
28. Lynch D. R. Guttmann R. P. (2002) Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J. Pharmacol. Exp. Ther. 300, 717 723.
29. Maehama T. Dixon J. E. (1999) PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol. 9, 125 128.
30. Manabe S. Lipton S. A. (2003) Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest. Ophthalmol. Vis. Sci. 44, 385 392.
31. Nakazawa T., Tamai M. Mori N. (2002) Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest. Ophthalmol. Vis. Sci. 43, 3319 3326.
32. Nakazawa T., Shimura M., Tomita H., Akiyama H., Yoshioka Y., Kudou H. Tamai M. (2003) Intrinsic activation of PI3K/Akt signaling pathway and its neuroprotective effect against retinal injury. Curr. Eye Res. 26, 55 63.
33. Nakazawa T., Shimura M., Endo S., Takahashi H., Mori N. Tamai M. (2005) N-Methyl-D-Aspartic acid suppresses Akt activity through protein phosphatase in retinal ganglion cells. Mol. Vis. 11, 1173 1182.
34. Nucci C., Tartaglione R., Rombola L., Morrone L. A., Fazzi E. Bagetta G. (2005) Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26, 935 941.
35. Odriozola L., Singh G., Hoang T. Chan A. M. (2007) Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J. Biol. Chem. 282, 23306 23315.
36. Osborne N. N., Chidlow G., Layton C. J., Wood J. P., Casson R. J. Melena J. (2004) Optic nerve and neuroprotection strategies. Eye 18, 1075 1084.
37. Ouyang Y. B., Tan Y., Comb M., Liu C. L., Martone M. E., Siesjo B. K. Hu B. R. (1999) Survival- and death-promoting events after transient cerebral ischemia: phosphorylation of Akt, release of cytochrome C and Activation of caspase-like proteases. J. Cereb. Blood Flow Metab. 19, 1126 1135.
38. Quigley H. A. (1995) Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust. NZ J. Ophthalmol. 23, 85 91.
39. Quigley H. A. (1999) Neuronal death in glaucoma. Prog. Retin. Eye Res. 18, 39 57.
40. Resnikoff S., Pascolini D., Etya'ale D., Kocur I., Pararajasegaram R., Pokharel G. P. Mariotti S. P. (2004) Global data on visual impairment in the year 2002. Bull. World Health Organ. 82, 844 851.
41. Saito A., Hayashi T., Okuno S., Ferrand-Drake M. Chan P. H. (2003) Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. J. Neurosci. 23, 1710 1718.
42. Seo M. S., Kim S. H., Ahn Y. M., Kim Y., Jeon W. J., Yoon S. C., Roh M. S., Juhnn Y. S. Kim Y. S. (2007) The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex. Int. J. Neuropsychopharmacol. 10, 359 368.
43. Sucher N. J., Aizenman E. Lipton S. A. (1991) N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J. Neurosci. 11, 966 971.
44. Sucher N. J., Lipton S. A. Dreyer E. B. (1997) Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 37, 3483 3493.
45. Vlahos C. J., Matter W. F., Hui K. Y. Brown R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241 5248.
46. van Weeren P. C., de Bruyn K. M., de Vries-Smits A. M., van Lint J. Burgering B. M. (1998) Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem. 273, 13150 13156.
47. Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B. Korsmeyer S. J. (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285 291.
48. Yoneda S., Tanihara H., Kido N., Honda Y., Goto W., Hara H. Miyawaki N. (2001) Interleukin-1beta mediates ischemic injury in the rat retina. Exp. Eye Res. 73, 661 667.
49. Zha J., Harada H., Yang E., Jockel J. Korsmeyer S. J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619 628.